ArticleThe Journal of pathology2025

Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma.

Spencer D Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.